✦ LIBER ✦

6603 A phase II study of erlotinib in patients (pts) with advanced pancreatic cancer (APC) who are refractory to gemcitabine (G)

✍ Scribed by Iyer, R.; Khushalani, N.; Tan, W.; Litwin, A.; LeVea, C.; Hutson, A.; Tucker, C.; Ma, W.; Fakih, M.; Adjei, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib in gemcita

✍ Renouf, D.J.; Tang, P.A.; Hedley, D.; Chen, E.; Kamel-Reid, S.; Tsao, M.S.; Tran 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 435 KB

Phase II study of gemcitabine in patient

✍ Camichael, J.; Fink, U.; Russell, R.C.G.; Spittie, M.F.; Harris, A.; Spiessi, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 163 KB

328 POSTER Phase II study of MTOR-inhibi

✍ M. Javle; D. Fogelman; A. Kaseb; G. Varadhachary; R. Wolff; J. Abbruzzese 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

6590 A phase II study of erlotinib plus

✍ Nakachi, K.; Okusaka, T.O.; Funakoshi, A.F.; Ioka, T.I.; Yamao, K.Y.; Ohkawa, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase II study of a fixed dose-rate infu

✍ J. Feliu; P. Borrega; A. León; L. López-Gómez; M. López; J. Castro; C. Belda-Ini 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 287 KB

Erratum to: Phase II Study of Gemcitabin

✍ Philip Q. Bao; Ramesh K. Ramanathan; Alyssa Krasinkas; Nathan Bahary; Barry C. L 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 107 KB